These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6662552)

  • 41. A novel cell line, MDA-kb2, that stably expresses an androgen- and glucocorticoid-responsive reporter for the detection of hormone receptor agonists and antagonists.
    Wilson VS; Bobseine K; Lambright CR; Gray LE
    Toxicol Sci; 2002 Mar; 66(1):69-81. PubMed ID: 11861974
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of specific glucocorticoid receptor in the Syrian hamster testis.
    Ortlip SA; Li SA; Li JJ
    Endocrinology; 1981 Nov; 109(5):1331-8. PubMed ID: 7297480
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Testosterone at high concentrations interacts with the human androgen receptor similarly to dihydrotestosterone.
    Grino PB; Griffin JE; Wilson JD
    Endocrinology; 1990 Feb; 126(2):1165-72. PubMed ID: 2298157
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Androgens and glucocorticoids modulate heparin-binding growth factor I mRNA accumulation in DDT1 cells as analyzed by in situ hybridization.
    Harris SE; Smith RG; Zhou H; Mansson PE; Malark M
    Mol Endocrinol; 1989 Nov; 3(11):1839-44. PubMed ID: 2481816
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line.
    Poulin R; Baker D; Labrie F
    Breast Cancer Res Treat; 1988 Oct; 12(2):213-25. PubMed ID: 3242650
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Atypical androgen receptor in the human melanoma cell line IIB-MEL-J.
    Morvillo V; Luthy IA; Bravo AI; Capurro MI; Donaldson M; Quintans C; Calandra RS; Mordoh J
    Pigment Cell Res; 1995 Jun; 8(3):135-41. PubMed ID: 7567789
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Non-classical androgenic actions of RU38486 in androgen-responsive Shionogi carcinoma 115 cells in serum-free culture.
    Lu J; Matsumoto K; Nishizawa Y; Tanaka A; Hirose T; Sato B
    J Steroid Biochem Mol Biol; 1991 Sep; 39(3):329-35. PubMed ID: 1911422
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endocrine-responsive pancreatic carcinoma: steroid binding and cytotoxicity studies in human tumor cell lines.
    Benz C; Hollander C; Miller B
    Cancer Res; 1986 May; 46(5):2276-81. PubMed ID: 3697973
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Corticoids and human skin fibroblasts: intracellular specific binding in relation to growth inhibition.
    Ponec M; De Kloet ER; Kempenaar JA
    J Invest Dermatol; 1980 Oct; 75(4):293-6. PubMed ID: 7430694
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation of growth and epidermal growth factor receptor levels of LNCaP prostate tumor cells by different steroids.
    Schuurmans AL; Bolt J; Voorhorst MM; Blankenstein RA; Mulder E
    Int J Cancer; 1988 Dec; 42(6):917-22. PubMed ID: 3263955
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vas deferens epithelial cells in subculture: a model to study androgen regulation of gene expression.
    Dassouli A; Darne C; Fabre S; Manin M; Veyssière G; Jean CI
    J Mol Endocrinol; 1995 Oct; 15(2):129-41. PubMed ID: 8800638
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of the androgen receptor from a Syrian hamster ductus deferens tumor cell line (DDT1).
    Norris JS; Kohler PO
    Science; 1976 May; 192(4242):898-900. PubMed ID: 179138
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Breast cancer: from estrogen to androgen receptor.
    Andò S; De Amicis F; Rago V; Carpino A; Maggiolini M; Panno ML; Lanzino M
    Mol Cell Endocrinol; 2002 Jul; 193(1-2):121-8. PubMed ID: 12161011
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Androgen binding in peripheral tissues of fetal rhesus macaques: effects of androgen metabolism in liver.
    Abdelgadir SE; Connolly PB; Resko JA
    J Steroid Biochem Mol Biol; 1990 Nov; 37(4):545-51. PubMed ID: 2278838
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hormonal regulation of prostate-specific antigen (PSA) glycoprotein in the human prostatic adenocarcinoma cell line, LNCaP.
    Montgomery BT; Young CY; Bilhartz DL; Andrews PE; Prescott JL; Thompson NF; Tindall DJ
    Prostate; 1992; 21(1):63-73. PubMed ID: 1379363
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dihydrotestosterone stimulates 5 alpha-reductase activity in pubic skin fibroblasts.
    Mowszowicz I; Melanitou E; Kirchhoffer MO; Mauvais-Jarvis P
    J Clin Endocrinol Metab; 1983 Feb; 56(2):320-5. PubMed ID: 6218182
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 1alpha,25-dihydroxyvitamin D3 actions in LNCaP human prostate cancer cells are androgen-dependent.
    Zhao XY; Ly LH; Peehl DM; Feldman D
    Endocrinology; 1997 Aug; 138(8):3290-8. PubMed ID: 9231780
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protein kinase C mediated anti-proliferative glucocorticoid-sphinganine synergism in cultured Pollard III prostate tumor cells.
    Sosnowski J; Stetter-Neel C; Cole D; Durham JP; Mawhinney MG
    J Urol; 1997 Jul; 158(1):269-74. PubMed ID: 9186373
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prolactin influences upon androgen action in male accessory sex organs.
    Thomas JA; Keenan EJ
    Adv Sex Horm Res; 1976; 2():425-70. PubMed ID: 189591
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular cloning of TA16, a transcriptional repressor that may mediate glucocorticoid-induced growth arrest of leiomyosarcoma cells.
    Fan W; Ma JX; Cheng L; Norris JS
    Mol Endocrinol; 1997 Aug; 11(9):1342-52. PubMed ID: 9259324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.